513
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Tolerability of solifenacin and oxybutynin immediate release in older (>65 years) and younger (≤65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study

, , , , , , , , , , & show all
Pages 375-382 | Accepted 16 Nov 2010, Published online: 23 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Cecilia Quarracino, Matilde Otero-Losada, Francisco Capani & Santiago Pérez-Lloret. (2020) State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson’s disease. Expert Opinion on Pharmacotherapy 21:4, pages 445-457.
Read now
Adrian Wagg, Victor W. Nitti, Con Kelleher, David Castro-Diaz, Emad Siddiqui & Todd Berner. (2016) Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinics. Current Medical Research and Opinion 32:4, pages 621-638.
Read now

Articles from other publishers (20)

William Gibson, Theodore Johnson, Ruth Kirschner‐Hermanns, George Kuchel, Alayne Markland, Susie Orme, Joan Ostaszkiewicz, George Szonyi, Jean Wyman & Adrian Wagg. (2020) Incontinence in frail elderly persons: Report of the 6th International Consultation on Incontinence. Neurourology and Urodynamics 40:1, pages 38-54.
Crossref
. (2019) Harninkontinenz bei geriatrischen Patienten, Diagnostik und Therapie. Aktuelle Urologie 50:S 01, pages s11-s59.
Crossref
Frances C. Hsu, Chandler E. Weeks, Shelley S. Selph, Ian Blazina, Rebecca S. Holmes & Marian S. McDonagh. (2019) Updating the evidence on drugs to treat overactive bladder: a systematic review. International Urogynecology Journal 30:10, pages 1603-1617.
Crossref
Silken A. Usmani, Kristine Reckenberg, Olivia Johnson, Paul M. Stranges, Besu F. Teshome, Clark D. Kebodeaux & Scott Martin Vouri. (2019) Relative Risk of Adverse Events and Treatment Discontinuations Between Older and Non-Older Adults Treated with Antimuscarinics for Overactive Bladder: A Systematic Review and Meta-Analysis. Drugs & Aging 36:7, pages 639-645.
Crossref
Sheng‐Fu Chen & Hann‐Chorng Kuo. (2018) Therapeutic efficacy of low‐dose (25 mg) mirabegron therapy for patients with mild to moderate overactive bladder symptoms due to central nervous system diseases. LUTS: Lower Urinary Tract Symptoms 11:2, pages O53-O58.
Crossref
Adrian Wagg. 2019. Contemporary Pharmacotherapy of Overactive Bladder. Contemporary Pharmacotherapy of Overactive Bladder 267 290 .
C. Chesnel, A. Charlanes, C. Hentzen, N. Turmel, X. Biardeau, C. Brochard, S. Campagne, G. Capon, X. Deffieux, B. Fatton, X. Gamé, R. Haddad, C. Jeandel, J. Kerdraon, P. Manceau, P. Mares, M. Mezzadri, P. Mongiat-Artus, A.-C. Petit, B. Peyronnet, J.-M. Soler, C. Thuillier, J.-M. Vetel, G. Robain & G. Amarenco. (2018) Effets cardio-vasculaires des traitements anticholinergiques à visée vésicale chez la personne âgée : une revue. Progrès en Urologie 28:7, pages 361-369.
Crossref
Edwin C. K. Tan, Duangjai Lexomboon, Gunilla Sandborgh‐Englund, Ylva Haasum & Kristina Johnell. (2017) Medications That Cause Dry Mouth As an Adverse Effect in Older People: A Systematic Review and Metaanalysis. Journal of the American Geriatrics Society 66:1, pages 76-84.
Crossref
Kristin D. Kistler, Yingxin Xu, Kelly H. Zou, Fady Ntanios, Douglass S. Chapman & Xuemei Luo. (2017) Systematic literature review of clinical trials evaluating pharmacotherapy for overactive bladder in elderly patients: An assessment of trial quality. Neurourology and Urodynamics 37:1, pages 54-66.
Crossref
Scott Martin Vouri, Clark D. Kebodeaux, Paul M. Stranges & Besu F. Teshome. (2017) Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis. Archives of Gerontology and Geriatrics 69, pages 77-96.
Crossref
Adrian Wagg, William Gibson, Joan Ostaszkiewicz, Theodore JohnsonIIIIII, Alayne Markland, Mary H. Palmer, George Kuchel, George Szonyi & Ruth Kirschner-Hermanns. (2015) Urinary incontinence in frail elderly persons: Report from the 5th International Consultation on Incontinence. Neurourology and Urodynamics 34:5, pages 398-406.
Crossref
Adrian Wagg. 2015. Overactive Bladder. Overactive Bladder 203 221 .
Junsoo Park, Ji-Youn Chun, Jang Hwan Kim, Si-yeol Cheon, Miho Song, Myung-Soo Choo, Kyu-Sung Lee, Seung-June Oh, Joon Chul Kim, Jong Bo Choi, Ju Tae Seo & Sung Yong Cho. (2014) A prospective, observational study to assess the association between dry mouth and solifenacin treatment in patients with overactive bladder syndrome. International Urology and Nephrology 47:2, pages 235-242.
Crossref
W. Gibson, A. Athanasopoulos, H. Goldman, H. Madersbacher, D. Newman, J. Spinks, J. J. Wyndaele & A. Wagg. (2014) Are we shortchanging frail older people when it comes to the pharmacological treatment of urgency urinary incontinence?. International Journal of Clinical Practice 68:9, pages 1165-1173.
Crossref
Karl-Erik Andersson. 2014. Bladder Dysfunction in the Adult. Bladder Dysfunction in the Adult 121 222 .
Joy A. Greer, Lily A. Arya & Ariana L. Smith. (2013) Urinary Incontinence: Diagnosis and Treatment in the Elderly. Current Translational Geriatrics and Experimental Gerontology Reports 2:2, pages 66-75.
Crossref
Adrian S. Wagg. (2012) Antimuscarinic Treatment in Overactive Bladder. Drugs & Aging 29:7, pages 539-548.
Crossref
Alex Gomelsky & Roger R. Dmochowski. (2012) Antimuscarinic therapy – what is new?. Drug Discovery Today: Therapeutic Strategies 9:1, pages e21-e25.
Crossref
Dudley Robinson & Linda Cardozo. (2011) Solifenacin for the treatment of overactive bladder. Therapy 8:6, pages 691-701.
Crossref
Roger R Dmochowski & Alex Gomelsky. (2011) Update on the treatment of overactive bladder. Current Opinion in Urology 21:4, pages 286-290.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.